SCHEMBL8484731

SCHEMBL8484731

Cc1oncc1C(=S)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 10/20 0.71
▸ NPC1 O15118 2/20 0.71
▸ RAB9A P51151 2/20 0.71
▸ LMNA P02545 2/20 0.71
▸ HTT P42858 2/20 0.71
▸ SMN1; SMN2 Q16637 2/20 0.71
▸ GMNN O75496 1/20 0.71
▸ TP53 P04637 1/20 0.71
▸ CYP1A2 P05177 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ HTR1A P08908 1/20 0.71
▸ THRB P10828 1/20 0.71
▸ PIM1 P11309 1/20 0.71
▸ CYP2C9 P11712 1/20 0.71
▸ MAOA P21397 1/20 0.71
▸ SLC6A2 P23975 1/20 0.71
▸ HTR2A P28223 1/20 0.71
▸ AGTR1 P30556 1/20 0.71
▸ CCKBR P32239 1/20 0.71
▸ MC4R P32245 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leflunomide SCHEMBL1243495 0.83 RAB9A (1.00) DHODHNPC1RAB9ALMNAHTT
Leflunomide SCHEMBL5057 0.83 RAB9A (1.00) DHODHNPC1RAB9ALMNAHTT
Leflunomide SCHEMBL29271960 0.80 RAB9A (0.92) DHODHNPC1RAB9ALMNAHTT
SCHEMBL11428900 0.78 RAB9A (0.88) DHODHNPC1RAB9ALMNAHTT
SCHEMBL8812525 0.77 RAB9A (0.86) DHODHNPC1RAB9ALMNAHTT
Leflunomide SCHEMBL18584841 0.76 RAB9A (0.84) DHODHNPC1RAB9ALMNAHTT
SCHEMBL7459817 0.76 DHODH (0.76) DHODHNPC1RAB9ALMNAHTT
SCHEMBL11320933 0.75 DHODH (0.67) DHODHNPC1RAB9ALMNAHTT
SCHEMBL9093812 0.75 DHODH (0.67) DHODHNPC1RAB9ALMNAHTT
SCHEMBL12356679 0.74 DHODH (0.82) DHODHNPC1RAB9ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760066-A AIDS, ATHEROSCLEROSIS, CANCER SUGEN, INC. (US) 1998-06-02 — — US claimed
WO-1996033179-A1 THIOAMIDES DERIVATES AND THEIR USE AS INHIBITORS OF HYPER-PROLIFERATIVE CELL GROWTH SUGEN, INC. (US) 1996-10-24 — — WO claimed
US-5914343-A TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, HOST VERSUS GRAFT REJECTION SUGEN, INC. (US) 1999-06-22 — — US disclosed
US-5760066-A AIDS, ATHEROSCLEROSIS, CANCER SUGEN, INC. (US) 1998-06-02 — — US disclosed
US-5721277-A TREATING CANCER, BLOOD VESSEL PROLIFERATION DISORDERS, FIBROTIC DISORDERS SUGEN, INC. (US) 1998-02-24 — — US disclosed
WO-1996033179-A1 THIOAMIDES DERIVATES AND THEIR USE AS INHIBITORS OF HYPER-PROLIFERATIVE CELL GROWTH SUGEN, INC. (US) 1996-10-24 — — WO disclosed
Send feedback